In Vitro Fertilization Market Size to be Worth USD 36.51 Billion in 2028 | Emergen Research

The Integrated In-vitro Fertilization (IVF) market has been experiencing significant growth in recent years. This is due to several factors, including increasing infertility rates, advancements in technology, and rising awareness about infertility treatments. The global In Vitro Fertilization (IVF) market size is expected to reach USD 36.51 Billion at a steady revenue CAGR of 9.1% in 2028, according to latest analysis by Emergen Research.

Several factors drive the growth of the Integrated In-vitro Fertilization market. One of the key drivers is the rising infertility rates across the globe. According to the World Health Organization, one in every four couples in developing countries is affected by infertility. Furthermore, the increasing trend of delayed pregnancies, lifestyle changes, and the rise in the number of same-sex marriages have contributed to the growth of the market.

Advancements in technology have also played a significant role in the growth of the Integrated In-vitro Fertilization market. The introduction of pre-implantation genetic screening (PGS) and pre-implantation genetic diagnosis (PGD) has improved the success rates of IVF treatments. Additionally, the use of electronic witnessing systems and time-lapse imaging systems has helped improve embryo selection and implantation success rates.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/19

However, the market also faces several challenges, including high treatment costs and ethical concerns. The high cost of IVF treatments remains a significant barrier, limiting the accessibility of the treatment to many patients. Additionally, ethical concerns surrounding the use of assisted reproductive technology (ART) have led to regulatory restrictions and limitations on research.

Despite these challenges, the Integrated In-vitro Fertilization market is poised for growth in the coming years. Several growth factors are expected to contribute to this growth. For instance, the increasing availability of insurance coverage for fertility treatments, rising public awareness about fertility treatments, and the growth of medical tourism are expected to fuel the market's growth.

Major Companies and Competitive Landscape:
The In Vitro Fertilization (IVF) market is highly competitive, with several key players dominating the market. These players focus on innovation, strategic collaborations, and mergers and acquisitions to maintain their market position and gain a competitive advantage.

Some of the major players in the IVF market include Vitrolife AB, CooperSurgical, Inc., Thermo Fisher Scientific Inc., The Baker Company, Inc., Kitazato Corporation, Cook Medical, Inc., Esco Micro Pte. Ltd., OvaScience, Boston IVF, and EMD Serono Inc.

CooperSurgical Inc. is a leading player in the IVF market, offering a comprehensive range of products and services for reproductive health. The company has a strong presence in the US and Europe, with a focus on expanding its market presence in Asia and the Middle East. In 2020, CooperSurgical Inc. acquired Reprogenetics, a leader in pre-implantation genetic testing (PGT) and diagnostic services, to strengthen its position in the IVF market.

Vitrolife AB is another prominent player in the IVF market, providing a range of IVF media, instruments, and services. The company has a global presence, with a focus on expanding its market share in emerging markets such as China and India. In 2020, Vitrolife AB acquired CTI Life Sciences, a leading provider of quality control solutions for cell therapy and regenerative medicine, to strengthen its position in the IVF market.

Merck KGaA is a diversified healthcare company with a strong presence in the IVF market. The company provides a range of IVF products and services, including IVF media, instruments, and services. Merck KGaA has a strong focus on innovation and research, with a focus on developing new products and services in the IVF market. In 2020, the company launched Gavi, a new IVF media designed to improve embryo quality and implantation rates.

Thermo Fisher Scientific Inc. is a leading provider of IVF products and services, including IVF media, instruments, and services. The company has a strong focus on research and development, with a focus on developing new products and services to improve IVF outcomes. In 2020, Thermo Fisher Scientific Inc. acquired Mesa Biotech, a leading provider of rapid molecular diagnostic tests for infectious diseases, to expand its product portfolio in the IVF market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/19

Segmentation Insights for In Vitro Fertilization Market Report:

Emergen Research has conducted a segmentation of the global In Vitro Fertilization (IVF) market on the basis of procedure, product, end-use, and region. The procedure segment is divided into Fresh Donor, Fresh Non-Donor, Frozen Donor, and Frozen Non-Donor, with revenues in USD Billion from 2018 to 2028. The product segment is divided into Reagents, Cryopreservation media, Ovum processing media, Embryo culture media, Sperm processing media, Equipment, and Accessories, with respective revenues in USD Billion. The equipment segment is further divided into Sperm separation system, Imaging system, Cabinet, Incubators, Ovum aspiration pump, Micro manipulation system, and Gas analyzer, with revenues in USD Billion from 2018 to 2028. The end-use segment is divided into Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, and Cryobanks, with respective revenues in USD Billion. Lastly, the regional outlook is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with revenues in USD Billion from 2018 to 2028.

The procedure segment in the global IVF market is expected to grow in the forecast period due to rising infertility rates and increasing awareness of IVF treatments. The product segment includes various media and equipment used in IVF procedures. The equipment segment is expected to grow as more sophisticated equipment is developed to improve the efficiency and success rates of IVF procedures. The end-use segment includes Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, and Cryobanks, which cater to patients seeking IVF treatments and storage of reproductive cells.

In terms of region, North America dominates the global IVF market due to the presence of key players and a high adoption rate of IVF procedures. Europe follows closely, with countries such as Germany, the UK, France, Spain, and BENELUX contributing significantly to the market. The Asia Pacific region is expected to experience significant growth in the forecast period, driven by increasing demand for IVF procedures in countries such as China, India, Japan, and South Korea. Latin America and the Middle East & Africa regions are also expected to experience growth in the coming years due to rising awareness and adoption of IVF procedures.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.